Showing results (151-160 of 287) with videos related to
Sort By:
Pageof 29
International Clinical Psychopharmacology|August 5, 1998
Implications of brain imaging for the management of schizophreniaS Nyberg, U Nilsson, Y Okubo, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 27, 1998
PET imaging of central 5-HT2A receptors with carbon-11-MDL 100,907H Ito, S Nyberg, C Halldin, et al.Annals of Nuclear Medicine|February 1, 1996
Effects of cocaine on [11C]norepinephrine and [11C] beta-CIT uptake in the primate peripheral organs measured by PETT Suhara, L Farde, C Halldin, et al.Acta Psychiatrica Scandinavica|May 1, 1993
Lack of association between schizophrenia and alleles in the dopamine D3 receptor geneE Jönsson, L Lannfelt, P Sokoloff, et al.Neuroradiology|January 1, 1986
Radionuclide cisternography and computed tomography in 30 healthy volunteersG Bergstrand, G Oxenstierna, L Flyckt, et al.Biological Psychology|May 1, 1984
Bilateral skin conductance activity, clinical symptoms and CSF monoamine metabolite levels in unmedicated schizophrenics, differing in rate of habituationA Bartfai, G Edman, S E Levander, et al.The British Journal of Psychiatry : the Journal of Mental Science|September 1, 1985
Plasma amino acids in relation to cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy controlsL Bjerkenstedt, G Edman, L Hagenfeldt, et al.Acta Psychiatrica Scandinavica|August 1, 1986
Dexamethasone suppression test in schizophrenic patients before and during neuroleptic treatmentG Wik, F A Wiesel, P Eneroth, et al.Journal of Neurochemistry|July 1, 1984
5-hydroxytryptophol in human cerebrospinal fluid: conjugation, concentration gradient, relationship to 5-hydroxyindoleacetic acid, and influence of hereditary factorsO Beck, S Borg, G Edman, et al.Psychiatry Research|August 1, 1983
Cerebroventricular size and cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy volunteersH Nybäck, B M Berggren, T Hindmarsh, et al.Pageof 29